Second-generation NGK2D-CAR-T cells with a 4-1BB or CD27 co-stimulatory structural domain increased T cell persistence and tumor regression and demonstrated strong antitumor activity in TNBC cell cultures and mouse xenogeneic models (Han et al., 2018). The gene discussed is CD27; the disease is neoplasm.